Location:Home > Application > Cell Products Publications >
Background RKO cell line is a low differentiated colon cancer cell line developed by Michael Brattain. It contains wild-type P53, but it lacks human thyroid receptor nuclear receptor (h-TRβ1). RKO cell line is the parental cell line of RKO-E6 and RKO-AS45-1, and its P53 protein l…